Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Training Course in Preparing Stable Lyophilized Protein Formulations

Published: Tuesday, June 04, 2013
Last Updated: Tuesday, June 04, 2013
Bookmark and Share
New hands-on training course designed by Dr Jeff Schwegman and Dr John Carpenter.

SP Scientific has announced a new hands-on training course entitled 'Rapid and Rational Development of Stable Lyophilized Protein Formulations'.

Due to take place from September 17-20, 2013 the extended training course has been designed by renowned industry experts Dr Jeff Schwegman and Dr John Carpenter to provide valuable assistance to those involved in the development and manufacture of diagnostics, vaccines, and biologically based injectable drug products including monoclonal antibodies.

Today an increasing number of products being developed as vaccines, diagnostics, and injectable drugs are based upon biological molecules such asproteins, enzymes, and antibodies.

Companies involved in these markets use these molecules to develop testing kits to detect various disease states and their pre-cursers, to develop vaccines to prevent and or minimize infections and to develop protein based drugs, including monoclonal antibodies, to treat disease states in both humans and animals.

While discovery and development of these types of products has soared, traditional downstream development methodologies used in formulation and stabilization are often failing to achieve long term stability, consequently companies may find themselves unable to manufacture their products to meet the guidelines laid out by the FDA.

Lyophilization, or freeze-drying, is recognized as a process used to enhance the stability of many products; however, if not done properly on biologically based formulations, it can be extremely damaging to the physical structure of the molecule, rendering them inactive, aggregated, and potentially eliciting an immune response in patients.

Addressing this issue, the 4-day training course has been designed to enable people involved with lyophilization, at all levels of experience, to gain considerable knowledge about the rapid and rational development of stable lyophilized protein formulations and to reinforce their classroom training with extensive laboratory work.

Full details of this extensive hands-on training course to be held in SP Scientific's modern Warminster, PA laboratory / training facility is available at www.spscientific.com/ProteinHandsOn.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Sub-Visible Particles: Impact On Therapeutic Proteins
New LyoLearn webinar to run on 27th June 2013.
Friday, June 07, 2013
Methods for Evaluating Lyophilized Product
SP Scientific, a world leader in freeze drying technology, has announced a new LyoLearn webinar that will discuss standard methods for evaluating lyophilized products.
Tuesday, December 07, 2010
Scientific News
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Lemon Juice and Human Norovirus
Citric acid may prevent the highly contagious norovirus from infecting humans, scientists discovered from the German Cancer Research Center.
Study Backs Flu Vaccinations for Elderly
Brown University researchers found vaccines well matched to the year’s flu strain significantly reduce deaths and hospitalizations compared to when the match is poor, suggesting that vaccination indeed makes a difference.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Protein Found to Play a Key Role in Blocking Pathogen Survival
Calprotectin fends off microbial invaders by limiting access to iron, an important nutrient.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!